. (CALP)

$10.49 - (-)

Market Cap: -

As of 12/22/11 12:00 AM EST. Market closed.

(CALP)

. (CALP)

$10.49
- (-)

Market Cap: -

As of 12/22/11 12:00 AM EST. Market closed.

Add to Portfolio
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$10.49
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
$10.49
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
TUNSTALL KATHRYNDirectorNov 07, 2011 Option Exercise$10.5025,107263,6240Nov 07, 2011, 04:48 PM
MILLIGAN DAVID VDirectorNov 07, 2011 Option Exercise$10.5081,729858,1550Nov 07, 2011, 04:46 PM
MCAREE PETER FSr.VP and CFONov 07, 2011 Option Exercise$10.5062,786659,2530Nov 07, 2011, 04:45 PM
Manyak David MExec VP, Drug Discovery SvcsNov 07, 2011 Option Exercise$10.50423,2424,444,0410Nov 07, 2011, 04:43 PM
KRUKA WILLIAM C.Sr VP Corporate DevelopmentNov 07, 2011 Option Exercise$10.5082,240863,5200Nov 07, 2011, 04:40 PM
HRUSOVSKY E KEVINPresident & CEONov 07, 2011 Option Exercise$10.50826,7258,680,6130Nov 07, 2011, 04:39 PM
Griffith Joseph H. IVVP, Finance & ControllerNov 07, 2011 Option Exercise$10.5033,287349,5140Nov 07, 2011, 04:37 PM
CREAGER STEPHEN ESr. VP and General CounselNov 07, 2011 Option Exercise$10.5043,953461,5070Nov 07, 2011, 04:36 PM
Comstock Allan LDirectorNov 07, 2011 Option Exercise$10.5026,107274,1240Nov 07, 2011, 04:34 PM
CARTER DAVID WARRENDirectorNov 07, 2011 Option Exercise$10.5038,173400,8170Nov 07, 2011, 04:27 PM
CARTER DAVID WARRENDirectorNov 07, 2011 Option Exercise$10.50184,5891,938,1850Nov 07, 2011, 04:27 PM
BISHOP ROBERT CDirectorNov 07, 2011 Option Exercise$10.5026,814281,5470Nov 07, 2011, 04:26 PM
BILLET VANDirectorNov 07, 2011 Option Exercise$10.5025,107263,6240Nov 07, 2011, 04:24 PM
BAL BRUCE JSr.VP, OperationsNov 07, 2011 Option Exercise$10.50126,2791,325,9300Nov 07, 2011, 04:22 PM
HRUSOVSKY E KEVINPresident & CEOOct 31, 2011 Option Exercise$5.17179,407928,250826,725Nov 02, 2011, 04:44 PM
HRUSOVSKY E KEVINPresident & CEOAug 09, 2011 Option Exercise$6.792,47216,785647,318Nov 02, 2011, 04:44 PM
CREAGER STEPHEN ESr. VP and General CounselNov 01, 2011 Sale$10.475,00052,34443,953Nov 01, 2011, 04:39 PM
CREAGER STEPHEN ESr. VP and General CounselOct 03, 2011 Sale$10.455,00052,25048,953Oct 03, 2011, 04:50 PM
CREAGER STEPHEN ESr. VP and General CounselSep 01, 2011 Sale$7.525,00037,60251,104Sep 01, 2011, 04:20 PM
CARTER DAVID WARRENDirectorJul 15, 2011 Option Exercise$6.798,00654,3618,006Aug 24, 2011, 05:02 PM
CARTER DAVID WARRENDirectorAug 01, 2011 Option Exercise$6.7917,371117,949184,589Aug 24, 2011, 05:02 PM
CARTER DAVID WARRENDirectorJul 15, 2011 Option Exercise$6.7926,152177,572167,218Aug 24, 2011, 05:02 PM
CARTER DAVID WARRENDirectorAug 01, 2011 Option Exercise$6.7930,167204,83423,427Aug 24, 2011, 05:02 PM
CREAGER STEPHEN ESr. VP and General CounselAug 01, 2011 Sale$8.205,00041,00756,104Aug 02, 2011, 04:31 PM
CARTER DAVID WARRENDirectorJul 12, 2011 Option Exercise$6.791,0827,347141,066Jul 13, 2011, 04:51 PM
CARTER DAVID WARRENDirectorJul 11, 2011 Option Exercise$6.292,78717,519139,984Jul 13, 2011, 04:51 PM
Griffith Joseph H. IVVP, Finance & ControllerJul 01, 2011 Option Exercise$8.123973,22433,287Jul 05, 2011, 04:41 PM
MCAREE PETER FSr.VP and CFOJul 01, 2011 Sale$8.105,00040,47559,886Jul 05, 2011, 04:23 PM
CREAGER STEPHEN ESr. VP and General CounselJul 01, 2011 Sale$8.115,00040,54361,104Jul 05, 2011, 04:15 PM
Manyak David MExec VP, Drug Discovery SvcsJun 13, 2011 Sale$7.561,0988,301439,114Jun 15, 2011, 04:39 PM
Manyak David MExec VP, Drug Discovery SvcsJun 14, 2011 Sale$7.5418,902142,587420,212Jun 15, 2011, 04:39 PM
Manyak David MExec VP, Drug Discovery SvcsJun 08, 2011 Sale$7.1815,000107,700450,212Jun 09, 2011, 04:26 PM
Manyak David MExec VP, Drug Discovery SvcsJun 09, 2011 Sale$7.4810,00074,800440,212Jun 09, 2011, 04:26 PM
TUNSTALL KATHRYNDirectorJun 03, 2011 Option Exercise$7.204,37531,50025,107Jun 07, 2011, 04:40 PM
MILLIGAN DAVID VDirectorJun 03, 2011 Option Exercise$7.204,37531,50025,107Jun 07, 2011, 04:39 PM
CARTER DAVID WARRENDirectorJun 03, 2011 Option Exercise$7.204,37531,500137,197Jun 07, 2011, 04:33 PM
BISHOP ROBERT CDirectorJun 03, 2011 Option Exercise$7.206,25045,00026,814Jun 07, 2011, 04:32 PM
BILLET VANDirectorJun 03, 2011 Option Exercise$7.204,37531,50025,107Jun 07, 2011, 04:31 PM
Comstock Allan LDirectorJun 03, 2011 Option Exercise$7.204,37531,50026,107Jun 07, 2011, 04:30 PM
Manyak David MExec VP, Drug Discovery SvcsJun 01, 2011 Sale$7.1815,000107,700465,212Jun 02, 2011, 04:32 PM
Manyak David MExec VP, Drug Discovery SvcsMay 25, 2011 Sale$7.0815,000106,200480,212May 26, 2011, 04:27 PM
HRUSOVSKY E KEVINPresident & CEOApr 04, 2011 Option Exercise$6.808,75059,500640,587Apr 05, 2011, 04:22 PM
HRUSOVSKY E KEVINPresident & CEOMar 07, 2011 Option Exercise$6.5710,00065,700631,837Apr 05, 2011, 04:21 PM
HRUSOVSKY E KEVINPresident & CEOMar 03, 2011 Option Exercise$6.7662,500422,500621,837Apr 05, 2011, 04:21 PM
MCAREE PETER FSr.VP and CFOApr 01, 2011 Sale$6.705,00033,49064,886Apr 04, 2011, 04:25 PM
CREAGER STEPHEN ESr. VP and General CounselApr 01, 2011 Sale$6.665,00033,30566,104Apr 04, 2011, 04:23 PM
MCAREE PETER FSr.VP and CFOMar 07, 2011 Option Exercise$6.571,3508,87072,786Mar 07, 2011, 04:57 PM
MCAREE PETER FSr.VP and CFOMar 03, 2011 Option Exercise$6.763,17221,44369,886Mar 07, 2011, 04:57 PM
Manyak David MExec VP, Drug Discovery SvcsMar 03, 2011 Option Exercise$6.763,68724,924495,212Mar 07, 2011, 04:56 PM
Manyak David MExec VP, Drug Discovery SvcsMar 07, 2011 Option Exercise$6.571,4709,658498,242Mar 07, 2011, 04:56 PM
KRUKA WILLIAM C.Sr VP Corporate DevelopmentMar 07, 2011 Option Exercise$6.571,65110,84779,775Mar 07, 2011, 04:55 PM
KRUKA WILLIAM C.Sr VP Corporate DevelopmentMar 03, 2011 Option Exercise$6.764,08127,58876,926Mar 07, 2011, 04:55 PM
Griffith Joseph H. IVVP, Finance & ControllerMar 03, 2011 Option Exercise$6.763,13121,16632,241Mar 07, 2011, 04:49 PM
CREAGER STEPHEN ESr. VP and General CounselMar 07, 2011 Option Exercise$6.571,65110,84773,953Mar 07, 2011, 04:47 PM
CREAGER STEPHEN ESr. VP and General CounselMar 03, 2011 Option Exercise$6.764,11627,82471,104Mar 07, 2011, 04:47 PM
BAL BRUCE JSr.VP, OperationsMar 07, 2011 Option Exercise$6.571,4299,389126,279Mar 07, 2011, 04:46 PM
BAL BRUCE JSr.VP, OperationsMar 03, 2011 Option Exercise$6.763,13121,166123,208Mar 07, 2011, 04:46 PM
CARTER DAVID WARRENDirectorMar 02, 2011 Sale$6.5128,483185,4240Mar 04, 2011, 04:40 PM
MCAREE PETER FSr.VP and CFOFeb 28, 2011 Option Exercise$6.697194,81063,433Feb 28, 2011, 04:53 PM
Manyak David MExec VP, Drug Discovery SvcsFeb 28, 2011 Option Exercise$6.691,1067,399487,774Feb 28, 2011, 04:52 PM
KRUKA WILLIAM C.Sr VP Corporate DevelopmentFeb 28, 2011 Option Exercise$6.691,51010,10269,882Feb 28, 2011, 04:50 PM
HRUSOVSKY E KEVINPresident & CEOFeb 23, 2011 Option Exercise$6.5725,000164,250559,337Feb 28, 2011, 04:49 PM
CREAGER STEPHEN ESr. VP and General CounselFeb 28, 2011 Option Exercise$6.691,56410,46364,095Feb 28, 2011, 04:48 PM
BAL BRUCE JSr.VP, OperationsFeb 28, 2011 Option Exercise$6.691,3499,025116,714Feb 28, 2011, 04:47 PM
MCAREE PETER FSr.VP and CFOFeb 23, 2011 Option Exercise$6.571,97812,99562,152Feb 25, 2011, 04:29 PM
Manyak David MExec VP, Drug Discovery SvcsFeb 23, 2011 Option Exercise$6.571,79811,813485,880Feb 25, 2011, 04:28 PM
KRUKA WILLIAM C.Sr VP Corporate DevelopmentFeb 23, 2011 Option Exercise$6.572,57216,89867,642Feb 25, 2011, 04:27 PM
Griffith Joseph H. IVVP, Finance & ControllerFeb 23, 2011 Option Exercise$6.578995,90628,518Feb 25, 2011, 04:24 PM
CREAGER STEPHEN ESr. VP and General CounselFeb 23, 2011 Option Exercise$6.572,05813,52161,909Feb 25, 2011, 04:23 PM
BAL BRUCE JSr.VP, OperationsFeb 23, 2011 Option Exercise$6.571,79811,813114,313Feb 25, 2011, 04:23 PM
MCAREE PETER FSr.VP and CFOJan 18, 2011 Sale$6.497,50048,64958,630Jan 20, 2011, 04:31 PM
CREAGER STEPHEN ESr. VP and General CounselJan 18, 2011 Sale$6.4410,00064,44858,967Jan 20, 2011, 04:29 PM
CARTER DAVID WARRENDirectorNov 02, 2010 Sale$4.529,49542,90635,278Nov 03, 2010, 04:16 PM
CARTER DAVID WARRENDirectorNov 02, 2010 Sale$4.506,79530,58635,278Nov 03, 2010, 04:16 PM
CARTER DAVID WARRENDirectorNov 02, 2010 Sale$4.562,70012,320132,822Nov 03, 2010, 04:16 PM
Manyak David MExec VP, Drug Discovery SvcsOct 14, 2010 Sale$4.204,00016,800494,723Oct 15, 2010, 04:21 PM
Manyak David MExec VP, Drug Discovery SvcsOct 15, 2010 Sale$4.244,00016,960490,723Oct 15, 2010, 04:21 PM
Manyak David MExec VP, Drug Discovery SvcsOct 13, 2010 Sale$4.204,00016,800498,723Oct 13, 2010, 04:33 PM
Manyak David MExec VP, Drug Discovery SvcsOct 12, 2010 Sale$4.175,20021,700505,923Oct 13, 2010, 04:33 PM
Manyak David MExec VP, Drug Discovery SvcsOct 11, 2010 Sale$4.142,80011,580508,723Oct 13, 2010, 04:33 PM
KRUKA WILLIAM C.Sr VP Corporate DevelopmentAug 10, 2010 Sale$3.8012,30046,76871,200Aug 11, 2010, 04:29 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
TUNSTALL KATHRYNDirector11/07/2011263,624
MILLIGAN DAVID VDirector11/07/2011858,155
MCAREE PETER FSr.VP and CFO11/07/2011659,253
Manyak David MExec VP, Drug Discovery Svcs11/07/20114,444,041
KRUKA WILLIAM C.Sr VP Corporate Development11/07/2011863,520
HRUSOVSKY E KEVINPresident & CEO11/07/20118,680,613
Griffith Joseph H. IVVP, Finance & Controller11/07/2011349,514
CREAGER STEPHEN ESr. VP and General Counsel11/07/2011461,507
Comstock Allan LDirector11/07/2011274,124
CARTER DAVID WARRENDirector11/07/2011400,817
CARTER DAVID WARRENDirector11/07/20111,938,185
BISHOP ROBERT CDirector11/07/2011281,547
BILLET VANDirector11/07/2011263,624
BAL BRUCE JSr.VP, Operations11/07/20111,325,930
HRUSOVSKY E KEVINPresident & CEO10/31/2011928,250
HRUSOVSKY E KEVINPresident & CEO08/09/201116,785
CREAGER STEPHEN ESr. VP and General Counsel11/01/201152,344
CREAGER STEPHEN ESr. VP and General Counsel10/03/201152,250
CREAGER STEPHEN ESr. VP and General Counsel09/01/201137,602
CARTER DAVID WARRENDirector07/15/201154,361
CARTER DAVID WARRENDirector08/01/2011117,949
CARTER DAVID WARRENDirector07/15/2011177,572
CARTER DAVID WARRENDirector08/01/2011204,834
CREAGER STEPHEN ESr. VP and General Counsel08/01/201141,007
CARTER DAVID WARRENDirector07/12/20117,347
CARTER DAVID WARRENDirector07/11/201117,519
Griffith Joseph H. IVVP, Finance & Controller07/01/20113,224
MCAREE PETER FSr.VP and CFO07/01/201140,475
CREAGER STEPHEN ESr. VP and General Counsel07/01/201140,543
Manyak David MExec VP, Drug Discovery Svcs06/13/20118,301
Manyak David MExec VP, Drug Discovery Svcs06/14/2011142,587
Manyak David MExec VP, Drug Discovery Svcs06/08/2011107,700
Manyak David MExec VP, Drug Discovery Svcs06/09/201174,800
TUNSTALL KATHRYNDirector06/03/201131,500
MILLIGAN DAVID VDirector06/03/201131,500
CARTER DAVID WARRENDirector06/03/201131,500
BISHOP ROBERT CDirector06/03/201145,000
BILLET VANDirector06/03/201131,500
Comstock Allan LDirector06/03/201131,500
Manyak David MExec VP, Drug Discovery Svcs06/01/2011107,700
Manyak David MExec VP, Drug Discovery Svcs05/25/2011106,200
HRUSOVSKY E KEVINPresident & CEO04/04/201159,500
HRUSOVSKY E KEVINPresident & CEO03/07/201165,700
HRUSOVSKY E KEVINPresident & CEO03/03/2011422,500
MCAREE PETER FSr.VP and CFO04/01/201133,490
CREAGER STEPHEN ESr. VP and General Counsel04/01/201133,305
MCAREE PETER FSr.VP and CFO03/07/20118,870
MCAREE PETER FSr.VP and CFO03/03/201121,443
Manyak David MExec VP, Drug Discovery Svcs03/03/201124,924
Manyak David MExec VP, Drug Discovery Svcs03/07/20119,658
KRUKA WILLIAM C.Sr VP Corporate Development03/07/201110,847
KRUKA WILLIAM C.Sr VP Corporate Development03/03/201127,588
Griffith Joseph H. IVVP, Finance & Controller03/03/201121,166
CREAGER STEPHEN ESr. VP and General Counsel03/07/201110,847
CREAGER STEPHEN ESr. VP and General Counsel03/03/201127,824
BAL BRUCE JSr.VP, Operations03/07/20119,389
BAL BRUCE JSr.VP, Operations03/03/201121,166
CARTER DAVID WARRENDirector03/02/2011185,424
MCAREE PETER FSr.VP and CFO02/28/20114,810
Manyak David MExec VP, Drug Discovery Svcs02/28/20117,399
KRUKA WILLIAM C.Sr VP Corporate Development02/28/201110,102
HRUSOVSKY E KEVINPresident & CEO02/23/2011164,250
CREAGER STEPHEN ESr. VP and General Counsel02/28/201110,463
BAL BRUCE JSr.VP, Operations02/28/20119,025
MCAREE PETER FSr.VP and CFO02/23/201112,995
Manyak David MExec VP, Drug Discovery Svcs02/23/201111,813
KRUKA WILLIAM C.Sr VP Corporate Development02/23/201116,898
Griffith Joseph H. IVVP, Finance & Controller02/23/20115,906
CREAGER STEPHEN ESr. VP and General Counsel02/23/201113,521
BAL BRUCE JSr.VP, Operations02/23/201111,813
MCAREE PETER FSr.VP and CFO01/18/201148,649
CREAGER STEPHEN ESr. VP and General Counsel01/18/201164,448
CARTER DAVID WARRENDirector11/02/201042,906
CARTER DAVID WARRENDirector11/02/201030,586
CARTER DAVID WARRENDirector11/02/201012,320
Manyak David MExec VP, Drug Discovery Svcs10/14/201016,800
Manyak David MExec VP, Drug Discovery Svcs10/15/201016,960
Manyak David MExec VP, Drug Discovery Svcs10/13/201016,800
Manyak David MExec VP, Drug Discovery Svcs10/12/201021,700
Manyak David MExec VP, Drug Discovery Svcs10/11/201011,580
KRUKA WILLIAM C.Sr VP Corporate Development08/10/201046,768
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...